Evidence map›Paper›PMID 40918201›Full record

ArticleArtificial intelligence in medicine. Conference on Artificial Intelligence in Medicine (2005- )2025

Reinforcement Learning on Dyads to Enhance Medication Adherence.

Ziping Xu, Hinal Jajal, Sung Won Choi, Inbal Nahum-Shani, Guy Shani, Alexandra M Psihogios, Pei-Yao Hung, Susan A Murphy

Abstract read
In one paragraph

Article in Artificial intelligence in medicine. Conference on Artificial Intelligence in Medicine (2005- ), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ziping XuHarvard University, Cambridge, MA, USA.ORCID 0000-0002-2591-0356
Hinal JajalHarvard University, Cambridge, MA, USA.ORCID 0009-0008-4134-2433
Sung Won ChoiUniversity of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-6321-3834
Inbal Nahum-ShaniUniversity of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-6138-9089
Guy ShaniUniversity of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-7237-076X
Alexandra M PsihogiosNorthwestern University, Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0002-4111-1191
Pei-Yao HungUniversity of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-7415-901X
Susan A MurphyHarvard University, Cambridge, MA, USA.ORCID 0000-0002-2032-4286

Funding

Validating novel sleep sensors and devices in older adults with Alzheimer's diseaseP30AG073107 · NIA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI Sudeshna Das, Deepak Ganesan · 2021 to 2026
$32.0M
Pilot and Mentoring CoreP50DA054039 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LINDA M COLLINS, SUSAN A MURPHY · 2021 to 2026
$18.2M
TR&D3 - Rapid Translation of AI-powered Temporally Precise mHealth Interventions via Efficient and Embeddable Trustworthy Biomarker ImplementationsP41EB028242 · NIBIB · UNIVERSITY OF MEMPHIS · PI Santosh Kumar · 2020 to 2026
$9.5M
Personalized Digital Behavior Change Interventions to Promote Oral HealthUH3DE028723 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VIVEK SHETTY · 2022 to 2026
$3.8M
Phase I/II clinical trial of HDAC inhibition for GVHD prevention in children, adolescents, and young adultsR01CA249211 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHOI, SUNG WON · 2020 to 2024
$2.2M
University of Michigan Core Clinical Center for the BMT Research NetworkUG1HL069330 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUNG WON CHOI, Mary Mansour Riwes · 2017 to 2026
$1.8M
Patient-Oriented Research and Mentoring in Hematopoietic Cell TransplantationK24HL156896 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUNG WON CHOI · 2021 to 2026
$870k
NCI NIH HHS R01 CA249211NHLBI NIH HHS K24 HL156896NHLBI NIH HHS UG1 HL069330NIA NIH HHS P30 AG073107NIBIB NIH HHS P41 EB028242NIDA NIH HHS P50 DA054039NIDCR NIH HHS UH3 DE028723
6 · The paper itself

Abstract

Medication adherence is critical for the recovery of adolescents and young adults (AYAs) who have undergone hematopoietic cell transplantation. However, maintaining adherence is challenging for AYAs after hospital discharge, who experience both individual (e.g. physical and emotional symptoms) and interpersonal barriers (e.g., relational difficulties with their care partner, who is often involved in medication management). To optimize the effectiveness of a three-component digital intervention targeting both members of the dyad as well as their relationship, we propose a novel Multi-Agent Reinforcement Learning (MARL) approach to personalize the delivery of interventions. By incorporating the domain knowledge, the MARL framework, where each agent is responsible for the delivery of one intervention component, allows for faster learning compared with a flattened agent. Evaluation using a dyadic simulator environment, based on real clinical data, shows a significant improvement in medication adherence (approximately 3%) compared to purely random intervention delivery. The effectiveness of this approach will be further evaluated in an upcoming trial.

Indexed as

Digital HealthDyadic RelationshipsMedication AdherenceReinforcement Learning

Identifiers

PMID40918201
PMCPMC12413200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.